Aprea Therapeutics secures up to $34 million in financing By Investing.com
© Reuters. DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ:), a biopharmaceutical company specializing in precision oncology, announced today that it ...
© Reuters. DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ:), a biopharmaceutical company specializing in precision oncology, announced today that it ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.